{"name":"The Cooper Health System","slug":"the-cooper-health-system","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"immunology","drugs":[{"name":"Remifentanil, Propofol, and Desflurane","genericName":"Remifentanil, Propofol, and Desflurane","slug":"remifentanil-propofol-and-desflurane","indication":"Induction and maintenance of general anesthesia for surgical procedures","status":"marketed"},{"name":"TH-1 Dendritic Cell Immunotherapy","genericName":"TH-1 Dendritic Cell Immunotherapy","slug":"th-1-dendritic-cell-immunotherapy","indication":"Other","status":"phase_1"},{"name":"Bupivacaine Injectable Solution","genericName":"Bupivacaine Injectable Solution","slug":"bupivacaine-injectable-solution","indication":"Other","status":"marketed"},{"name":"Dexemedetomidine","genericName":"Dexemedetomidine","slug":"dexemedetomidine","indication":"Other","status":"marketed"},{"name":"IV opioid administration","genericName":"IV opioid administration","slug":"iv-opioid-administration","indication":"Other","status":"marketed"},{"name":"Tylenol, Ibuprofen, and Oxycodone","genericName":"Tylenol, Ibuprofen, and Oxycodone","slug":"tylenol-ibuprofen-and-oxycodone","indication":"Other","status":"marketed"},{"name":"dosing of Betamethasone","genericName":"dosing of Betamethasone","slug":"dosing-of-betamethasone","indication":"Other","status":"phase_1"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Tylenol and Ibuprofen only","genericName":"Tylenol and Ibuprofen only","slug":"tylenol-and-ibuprofen-only","indication":"Mild to moderate pain","status":"marketed"},{"name":"Remifentanil, Dexmedetomidine, and Desflurane","genericName":"Remifentanil, Dexmedetomidine, and Desflurane","slug":"remifentanil-dexmedetomidine-and-desflurane","indication":"General anesthesia for surgical procedures","status":"marketed"},{"name":"Exparel Injectable Solution","genericName":"Exparel Injectable Solution","slug":"exparel-injectable-solution","indication":"Infiltration anesthesia and nerve block for surgical anesthesia and postoperative analgesia","status":"marketed"},{"name":"Remifentanil and Desflurane","genericName":"Remifentanil and Desflurane","slug":"remifentanil-and-desflurane","indication":"Induction and maintenance of general anesthesia in adults and children","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Avastin, Alimta","genericName":"Avastin, Alimta","slug":"avastin-alimta","indication":"Metastatic colorectal cancer","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Bezlotoxumab Injection","genericName":"Bezlotoxumab Injection","slug":"bezlotoxumab-injection","indication":"Clostridioides difficile infection (CDI) — to reduce recurrence in patients at high risk","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"Chlorhexidine gluconate (4%)","genericName":"Chlorhexidine gluconate (4%)","slug":"chlorhexidine-gluconate-4","indication":"Oral antisepsis and plaque reduction","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Northera","genericName":"Northera","slug":"northera","indication":"Orthostatic hypotension","status":"marketed"}]}],"pipeline":[{"name":"Tylenol and Ibuprofen only","genericName":"Tylenol and Ibuprofen only","slug":"tylenol-and-ibuprofen-only","phase":"marketed","mechanism":"Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system, while ibuprofen reduces pain, fever, and inflammation by inhibiting cyclooxygenase (COX) enzymes peripherally and centrally.","indications":["Mild to moderate pain","Fever reduction","Headache","Muscle aches"],"catalyst":""},{"name":"Remifentanil, Dexmedetomidine, and Desflurane","genericName":"Remifentanil, Dexmedetomidine, and Desflurane","slug":"remifentanil-dexmedetomidine-and-desflurane","phase":"marketed","mechanism":"This is a combination of three anesthetic agents that work synergistically: remifentanil (opioid agonist), dexmedetomidine (alpha-2 adrenergic agonist), and desflurane (volatile anesthetic) to produce sedation, analgesia, and unconsciousness for surgical procedures.","indications":["General anesthesia for surgical procedures","Sedation and analgesia during anesthesia maintenance"],"catalyst":""},{"name":"Remifentanil, Propofol, and Desflurane","genericName":"Remifentanil, Propofol, and Desflurane","slug":"remifentanil-propofol-and-desflurane","phase":"marketed","mechanism":"This is a combination of three anesthetic agents that work together to induce and maintain general anesthesia through different mechanisms: remifentanil provides opioid analgesia, propofol induces sedation via GABA potentiation, and desflurane maintains anesthesia via volatile anesthetic action.","indications":["Induction and maintenance of general anesthesia for surgical procedures"],"catalyst":""},{"name":"TH-1 Dendritic Cell Immunotherapy","genericName":"TH-1 Dendritic Cell Immunotherapy","slug":"th-1-dendritic-cell-immunotherapy","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Avastin, Alimta","genericName":"Avastin, Alimta","slug":"avastin-alimta","phase":"phase_2","mechanism":"Avastin (bevacizumab) is a monoclonal antibody that targets vascular endothelial growth factor (VEGF), inhibiting angiogenesis and tumor growth.","indications":["Metastatic colorectal cancer","Non-small cell lung cancer","Glioblastoma","Metastatic renal cell carcinoma","Cervical cancer"],"catalyst":""},{"name":"Bezlotoxumab Injection","genericName":"Bezlotoxumab Injection","slug":"bezlotoxumab-injection","phase":"marketed","mechanism":"Bezlotoxumab is a monoclonal antibody that binds to and neutralizes Clostridioides difficile toxin B, preventing its pathogenic effects on the intestinal epithelium.","indications":["Clostridioides difficile infection (CDI) — to reduce recurrence in patients at high risk"],"catalyst":""},{"name":"Bupivacaine Injectable Solution","genericName":"Bupivacaine Injectable Solution","slug":"bupivacaine-injectable-solution","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Chlorhexidine gluconate (4%)","genericName":"Chlorhexidine gluconate (4%)","slug":"chlorhexidine-gluconate-4","phase":"marketed","mechanism":"Chlorhexidine gluconate is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, leading to rapid bactericidal and bacteriostatic effects.","indications":["Oral antisepsis and plaque reduction","Skin antisepsis and wound irrigation","Preoperative skin preparation","Oral rinse for gingivitis and periodontal disease prevention"],"catalyst":""},{"name":"Dexemedetomidine","genericName":"Dexemedetomidine","slug":"dexemedetomidine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Exparel Injectable Solution","genericName":"Exparel Injectable Solution","slug":"exparel-injectable-solution","phase":"marketed","mechanism":"Liposomal bupivacaine is an encapsulated local anesthetic that blocks nerve impulses by inhibiting sodium channel activity, providing prolonged pain relief after surgical procedures.","indications":["Infiltration anesthesia and nerve block for surgical anesthesia and postoperative analgesia"],"catalyst":""},{"name":"IV opioid administration","genericName":"IV opioid administration","slug":"iv-opioid-administration","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Northera","genericName":"Northera","slug":"northera","phase":"marketed","mechanism":"Muscarinic acetylcholine receptor M1, Adrenergic receptor","indications":["Orthostatic hypotension","Parkinson's disease"],"catalyst":""},{"name":"Remifentanil and Desflurane","genericName":"Remifentanil and Desflurane","slug":"remifentanil-and-desflurane","phase":"marketed","mechanism":"Remifentanil is an opioid agonist that binds mu receptors to provide analgesia and sedation, while desflurane is a volatile anesthetic that enhances CNS depression through GABA and other ion channel modulation.","indications":["Induction and maintenance of general anesthesia in adults and children","Analgesia and sedation in mechanically ventilated patients in intensive care settings"],"catalyst":""},{"name":"Tylenol, Ibuprofen, and Oxycodone","genericName":"Tylenol, Ibuprofen, and Oxycodone","slug":"tylenol-ibuprofen-and-oxycodone","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"dosing of Betamethasone","genericName":"dosing of Betamethasone","slug":"dosing-of-betamethasone","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNa09GcVlEWkljdGdfZ0t1elZaWncyV0l0djlfWXpFaW1XblZrZnN4WDZpUDVva3VsTERLU3JHc2RGNTFVSnBCbEVCal95MjBEazJQY2l1V0xTcnc3eHpibG5TOE5JcHo0X1dUT2FhV1pudlRZeXZlWXMzdEtnbVh4UWJpQnhycWtPZTlBTF83c1kwYTBaZGVLN2FXY0MyMENhbG50TUhXX3Q?oc=5","date":"2026-03-30","type":"pipeline","source":"Politico","summary":"New factories and supersized Obamacare premiums: North Carolina considers what Trump has wrought - Politico","headline":"New factories and supersized Obamacare premiums: North Carolina considers what Trump has wrought","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPWWlzeEZGNnFJWFhkaHdrc1hHV0xqd0h2SlY0UkptWkxVODk4cVJETVhQV0t1dmJqV0U2eFotV1pENWRzZV90UVlDOE5PZVY4b3V1VHpoTE5ndTRpZUd0c29rTmVkaFBCbGNRZmxwNmFGdjlFSUxRRkJwSlpMWEhTN1ZYX3BLbnpxdmJBQUJlZE5EeTRt?oc=5","date":"2026-03-09","type":"pipeline","source":"WXII","summary":"Roy Cooper unveils health care cost reduction proposals in Greensboro as part of his U.S. Senate campaign - WXII","headline":"Roy Cooper unveils health care cost reduction proposals in Greensboro as part of his U.S. Senate campaign","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPS2VYcjVFRDJqOTU4REtyX25kS3BsN0ZkSEpVX1lCUUlqVm1RMGZKZG04VVN6Zmw2LVYtbXFZT2diQUl0SktfUDZGTnVKOC1ERWFGU2EzMk5mTFFIRTRWUDd4djdzblFNcDcydGlnX0JUNk9ZVERfWWRERVNZUm0yd0stM0daS3FDa01aQVZZYUt0ck5WdzhwVDA3enhqX25QWm1mZVNGdmZzUQ?oc=5","date":"2025-08-22","type":"earnings","source":"The Business Journals","summary":"Cooper University Health Care sees revenue jump 14% in first half of 2025 - The Business Journals","headline":"Cooper University Health Care sees revenue jump 14% in first half of 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9EUnVma0ZfNFI5RHhvOVJybV95TGRCV05zRng0dGpRN01DeHQxUmd2eGhCeG5aV3VZSGVTbHp5a045ZUR5dEFlSlZWUDFVai1Ta0g5SFNGVGhudjc2dDR1QzFpTnhPX0RuZFk2bkxFS2JOcFMzY3dPVDRPMll5R2M?oc=5","date":"2025-07-30","type":"pipeline","source":"NJBIZ","summary":"Cooper University Hospital appoints first CNO - NJBIZ","headline":"Cooper University Hospital appoints first CNO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNR1d0M0llSHU2eUNHZHMwTjkydWhoSzlDYlR1SzNYMVFBRVlkNWNrRnRJZlhLLUViYTduV0w5SlJ5elBhTzZyYTctbUMtNVdnQS0xYjdpVlNFQmpLOW9XcHI0T2tKb3gxWXBDZFR0bW05VVMwS0tlZFNWT1hDem1vZjFUbGJBcG55ZnF5dGJ5MlRxenk0VGlqQUU1MHp0dVlZSjk3bWt3UmFHZGVrRHVscXQzMEk5bWpacWFsag?oc=5","date":"2025-07-24","type":"pipeline","source":"roi-nj.com","summary":"Shingler-Nace named chief nursing officer by Cooper University Health Care - roi-nj.com","headline":"Shingler-Nace named chief nursing officer by Cooper University Health Care - roi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQRkxHQndtV3RMVUxBSlp0eFRaSTV2NHdVOXhfajRhNFRXT3B4cmV1RkZ0Vm01U1Q2S0p0REZoNnUyUXkwOHJNdXJKQmluLUhldVMxWlVzRk9SU1BNSEUyVWs1enFFTmJvZE1QUl92UlFpeW4yTFB3SzZlSlpjM1VLcnlHMHN3a3VvZVcxNTNlaw?oc=5","date":"2025-07-16","type":"pipeline","source":"PwC","summary":"Medical cost trend: Behind the numbers 2026 - PwC","headline":"Medical cost trend: Behind the numbers 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOSlNDQ1NNcElVRWdyeHp5S2JMYW9sUGR1MGR1bDhXVHFvNGtNTV9qTGE3alB1YnRyUDdrRXJoZUJGOTRfdW1RS1lSQkpHUXFzamxVSVVDSk1VMmVxY1QxYVNYRmY0RGVLdnlLTHZQUVVHVHhoMkc2MnFPWDdDY001T29jbFZ0c2V0UEljdXFB?oc=5","date":"2025-05-28","type":"trial","source":"MobiHealthNews","summary":"Cooper Health System reports data security breach - MobiHealthNews","headline":"Cooper Health System reports data security breach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1sWnlRNWJsLU92WFJKQlFEeFF3OXhuY196REVxWkpsdlRmUE9OczRQSTRCVFN4NnlUR1RiWmdZMnNoUDM3RlFnTWFaMTYzRXNmUDJsc2h5Vm5nLW0xSkhKblFLeTYyV2N2elZiY2p4TkZDUQ?oc=5","date":"2025-05-28","type":"pipeline","source":"NJBIZ","summary":"Cyberattack hits Cooper Health, affecting nearly 60K patients - NJBIZ","headline":"Cyberattack hits Cooper Health, affecting nearly 60K patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQd1RiUmRMcnJKZjFKeDB2RW9ZVE9PZzZCNlp0Y0c3Q2kyUzhNbFMzc2hsX092SzhwNkNDQlJkMERfcWptR1lHeWg5Uk9ueF9JVVVQVUxNbW9aQ0ZST2NPNTIyM0d1MUMwWG1GSzlKQ2cyU2RGbU92NndmNkh1bU1sQXRpMzJZbnd6YkhfMnlwZXhZekFUOXA5V191REZwTU9BZVREZlZkVTVkUkp3YzBxV0pmd0RlZXZJanByd0l0RmVDN29MNFE?oc=5","date":"2025-04-09","type":"pipeline","source":"Novant Health","summary":"Novant Health breaks ground on new Center for Women’s Health at East Cooper Medical Center - Novant Health","headline":"Novant Health breaks ground on new Center for Women’s Health at East Cooper Medical Center","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNa2JhSWlSMGNkOHBmaEVhLUdpN3dvT3diVkljMVBtSjJMREJtZ2lmc1hMNGV6UkRZNkIydWx0THVHeTcyQWhBeEdmWHdsZVhuUloxVy1MQlZlaW1qa1c5M2cwRDM2S2htWWNhNTFTUF9OcFBTQlpBLVJzNWtWazRaVldqVmRwLTEweG51WnFoamRBVHdkcDloY0J4a19tOEdDLVJhazVkZDd1Z1NRQy1seHhUZmMzcHdib0tDT1piUF9NNnZoNHpwVTcwb1VKanF2?oc=5","date":"2024-03-19","type":"pipeline","source":"Wolters Kluwer","summary":"Cooper University Hospital of New Jersey achieves USP compliance success with Simplifi+ - Wolters Kluwer","headline":"Cooper University Hospital of New Jersey achieves USP compliance success with Simplifi+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNTUdWdGo2bzhRM2wtZEFZSVNqSFExM2ZEOGF5cmxfdEx0UzZIRGlvM1BtZEhJSHVtMUs2TDVpQXNWd25GMDZ6SGs2dGotZFQ4TTJvQ25yMzMzQjM1bEZtWU9UbjJmbnpBaG44bFJOTDdDSmVKVmZDanJfMk1aRjNlUFR2MVlxUVdTVFZyQm5Rd1Ntc0pGVTFsT05FLVNvT0ZndmRWVVRldTBhYjNhLUJkMml3UQ?oc=5","date":"2024-02-14","type":"pipeline","source":"Forbes","summary":"The Advantage Of Speed: Cooper Health Relies Upon Risk Alerts - Forbes","headline":"The Advantage Of Speed: Cooper Health Relies Upon Risk Alerts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPOElhVHZhQkl5RENGdW1LNFFRSGpISlRRcE5BRFo0bnM2VjVtWjZXclhucXlmbnkycnlfUzIwUVl4eXhSTDdHRThUVU5Nd2lEZUJaWnJ6bTdrcVc5SnhnWmRJSnVveGgtNGk4T2FyWHAycjY2T1RzOTRIZUR5STlJeE85TFcxaEwweGJfbkNjREM0cjlaekN3TUljMzYzSjNIOW1Hc19zTGtiSzFZR29vR1d4T2gtZnpicWpTeG5EYnZpTWdodUhESWRR?oc=5","date":"2022-12-15","type":"deal","source":"fiercehealthcare.com","summary":"New Jersey's Cooper University Health Care, Cape Regional Health System unveil $2.2B merger - fiercehealthcare.com","headline":"New Jersey's Cooper University Health Care, Cape Regional Health System unveil $2.2B merger","sentiment":"neutral"}],"patents":[],"drugCount":15,"phaseCounts":{"marketed":12,"phase_1":2,"phase_2":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}